Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial Phase I/II for the Use of Angiotensin-(1-7) in the Treatment of Severe Infection by Sars-CoV-2

NCT04633772 is registered in ClinicalTrials.gov with Erasme University Hospital as lead sponsor.

NCT NCT04633772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04633772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial Phase I/II for the Use of Angiotensin-(1-7) in the Treatment of Severe Infection by Sars-CoV-2
Lead sponsor
Erasme University Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
August 5, 2020
Completion date
November 1, 2021
Enrollment
112 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

infection, coronavirus, respiratory failure